Breast Cancer

RU011501I

Double Blind, Parallel Groups, Controlled, Randomized Phase II Trial to [...]

RU011501ITeam CZ2023-02-24T17:13:07+00:00

A Randomized Phase 2 Non-inferiority Trial of (Z) - endoxifen [...]

ATOS-Z-201Team CZ2023-02-24T17:09:25+00:00

A Randomized Phase III Trial of Eribulin Compared to Standard [...]

RU011201ITeam CZ2022-07-14T17:41:26+00:00

Phase II Randomized Study of Sorafenib Compared to Placebo When [...]

RC0731accruwebmaster2022-03-07T21:51:45+00:00

Phase II Study of Cardiac Safety and Tolerability of an [...]

RC0639accruwebmaster2022-03-07T21:51:29+00:00

Zoledronic Acid for Treatment of Osteopenia and Osteoporosis in Women [...]

MC05C8accruwebmaster2022-03-07T21:51:17+00:00

A Phase III, Open Label, Randomised, Controlled, Multi-centre Study to [...]

D0819C00003accruwebmaster2022-03-07T21:51:05+00:00

A Randomized Multicenter, Double-blind, Placebo-controlled Comparison of Chemotherapy Plus Trastuzumab [...]

BO25126accruwebmaster2022-03-07T21:50:55+00:00

A Phase 2/3, Multi-Center, Open-Label, Randomized Study of Weekly Nab®-Paclitaxel [...]

ABI-007-MBC-001accruwebmaster2022-03-07T21:50:46+00:00

The BEACON Study (Breast Cancer Outcomes With NKTR-102): A Phase [...]

11-PIR-11accruwebmaster2022-03-07T21:50:28+00:00